Use of statin during hospitalization improves the outcome after intracerebral hemorrhage

CNS Neuroscience and Therapeutics

Volumn 20, Issue 6, 2014, Pages 548-555

  Pan, Yue Song ^a   Jing, Jing ^a   Wang, Yi Long ^a   Zhao, Xing Quan ^a   Song, Bo ^b   Wang, Wen Juan ^a   Wang, David ^c   Liu, Gai Fen ^a   Liu, Li Ping ^a   Wang, Chun Xue ^a   Wang, Yong Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Hemorrhagic stroke; Intracerebral hemorrhage; Outcome; Statin

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNITOL; TRIACYLGLYCEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHINESE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLASGOW COMA SCALE; HEMATOMA; HOSPITALIZATION; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; RANKIN SCALE; RISK FACTOR; TELEPHONE INTERVIEW; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CEREBRAL HEMORRHAGE; CHINA; FOLLOW UP; MIDDLE AGED; NONPARAMETRIC TEST; REGISTER; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; CEREBRAL HEMORRHAGE; CHINA; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84900544482     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12274     Document Type: Article

References (33)

1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450-1460.
2. Jiang B, Wang WZ, Chen H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 2006;37:63-68.
3. Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008;39:1668-1674.
4. Wang Y, Cui L, Ji X, et al. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke 2011;6:355-361.
5. Wang WJ, Lu JJ, Wang YJ, et al. Clinical characteristics, management, and functional outcomes in Chinese patients within the first year after intracerebral hemorrhage: analysis from China National Stroke Registry. CNS Neurosci Ther 2012;18:773-780.
6. Seyfried D, Han Y, Lu D, Chen J, Bydon A, Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 2004;101:104-107.
7. Karki K, Knight RA, Han Y, et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke 2009;40:3384-3389.
8. Jung KH, Chu K, Jeong SW, et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 2004;35:1744-1749.
9. Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 2008;8:6-12.
10. FitzMaurice E, Wendell L, Snider R, et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008;39:2151-2154.
11. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009;40:2581-2584.
12. Gomis M, Ois A, Rodríguez-Campello A, et al. Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol 2010;17:443-448.
13. Eichel R, Khoury ST, Ben-Hur T, Keidar M, Paniri R, Leker RR. Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur J Neurol 2010;17:78-83.
14. Biffi A, Devan WJ, Anderson CD, et al. Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology 2011;76:1581-1588.
15. King NK, Tay VK, Allen JC, Ang BT. Prior statin use has no effect on survival after intracerebral hemorrhage in a multiethnic Asian patient cohort. Acta Neurochir Suppl 2012;114:343-346.
16. Dowlatshahi D, Demchuk AM, Fang J, et al. Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage. Stroke 2012;43:1518-1523.
17. Tapia-Pérez JH, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T. Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev 2013;36:279-287.
18. Mustanoja S, Strbian D, Putaala J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke 2013;44:2330-2332.
19. Goldstein LB, Amarenco P, Szarek M, et al. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology 2008;70:2364-2370.
20. Scheitz JF, Nolte CH, Endres M. Should statins be paused or discontinued after thrombolysis or acute intracerebral hemorrhage? No!. Stroke 2013;44:1472-1476.
21. Bustamante A, Montaner J. Statin therapy should not be discontinued in patients with intracerebral hemorrhage. Stroke 2013;44:2060-2061.
22. Goldstein LB. Statin therapy should be discontinued in patients with intracerebral hemorrhage. Stroke 2013;44:2058-2059.
23. Molina CA, Selim MH. Continued statin treatment after acute intracranial hemorrhage: fighting fire with fire. Stroke 2013;44:2062-2063.
24. Goldstein M, Barnett HJM, Orgogozo JM, et al. Recommendations on stroke prevention, diagnosis, and therapy. Report of the who task force on stroke and other cerebrovascular disorders. Stroke 1989;20:1407-1431.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
26. Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG, et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. Cent Eur Neurosurg 2009;70:15-20.
27. Winkler J, Shoup JP, Czap A, et al. Long-term improvement in outcome after intracerebral hemorrhage in patients treated with statins. J Stroke Cerebrovasc Dis 2013;22:541-545.
28. Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care 2007;45:S158-S165.
29. McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke 2012;43:2149-2156.
30. Hackam DG, Austin PC, Huang A, et al. Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol 2012;69:39-45.
31. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 2012;11:720-731.
32. Gong C, Hoff JT, Keep RF. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res 2000;871:57-65.
33. Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett 2000;283:230-232.